Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.88
+0.28 (5.00%)
Feb 2, 2026, 4:00 PM EST - Market closed
Aura Biosciences Employees
As of December 31, 2024, Aura Biosciences had 109 total employees, including 106 full-time and 3 part-time employees. The number of employees increased by 20 or 22.47% compared to the previous year.
Employees
109
Change (1Y)
20
Growth (1Y)
22.47%
Revenue / Employee
n/a
Profits / Employee
-$976,752
Market Cap
373.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 109 | 20 | 22.47% | 106 | 3 |
| Dec 31, 2023 | 89 | 17 | 23.61% | 88 | 1 |
| Dec 31, 2022 | 72 | 20 | 38.46% | 70 | 2 |
| Dec 31, 2021 | 52 | - | - | 52 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| Rocket Pharmaceuticals | 299 |
| Enanta Pharmaceuticals | 120 |
| Foghorn Therapeutics | 112 |
| Neumora Therapeutics | 95 |
| Lineage Cell Therapeutics | 77 |
| Aclaris Therapeutics | 64 |
| PepGen | 57 |
AURA News
- 2 months ago - Aura Biosciences to Participate in the 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 2 months ago - Aura Biosciences Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 5 months ago - Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 months ago - Aura Biosciences Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants - GlobeNewsWire
- 9 months ago - Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants - GlobeNewsWire
- 9 months ago - Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 9 months ago - Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire